|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Efficacy and safety of dutasteride,tamsulosin and their combination in a subpopulation of the Comb AT study:2-year results in Asian men with moderateto-severe BPH显示文摘 | Chung BH Roehrborn CG Siami P | 2008 | Prostate cancer and prostatic diseases2008，12，2： | 1 |
| 2 | The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the Comb AT study显示文摘 | ROEHRBOM CG SIAMI P BARKIN J | 2010 | Eur Urol2010，57，1： | 1 |
| 3 | Effect of dutas- teride, tamsulosin and the combination on patient-reported quality of life and treatment satisfaction in men with moderate-to-severe benign prostatic hyperplasia: 2-year data from the comb AT trial显示文摘 | BARKIN J ROEHRBOM CG SIAMI P | 2009 | BJU Int2009，103，7： | 1 |
| 4 | Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either mono therapy in men with benign prostatic hyperplasia (BPH)by base- lineeharaeteristics : 4 -year results from the randomized, double - blind Combination of Avodart and Tamsulosin (CombAT)trial显示文摘 | Roehrbom CG Barkin J Siami P | 2011 | BJU international2011，107，6： | 1 |
| 5 | Diary and patient-reported outcomes in patients with severe o,:eraetive bladder switching from tolterodine extended release 4 mg/day to solifenacin treatment: Anopen-label, flexible-dosing, multicentre study显示文摘 | Swift SE Siami P Forero-Sehwanhaeuser S | 2009 | Clin Drag Investig2009，29，5： | 1 |
| 6 | The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia : g - year results from the Combat study显示文摘 | Roehrborn CG Siami P Barkin J | 2010 | Eur Urol2010，57，： | 1 |
| 7 | Efficacy and safety of ciprofloxacin oral suspension versus trimethoprim-sulfamethoxazole oral suspension for treatment of older women with acute urinary tract infection显示文摘 | Gomolin I H Siami P F Reuning-Scherer J | 2001 | J Am Geriatr Soc2001，49，12： | 1 |
| 8 | The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia:4-year results from the CombAT study显示文摘 | Roehrborn CG Siami P Barkin J | | 0，，1： | 1 |
| 9 | Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either mono therapy in men with benign prostatic hyperplasia (BPH)by baselinecharacteris- tics:4 -year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT)trial显示文摘 | Roehrborn CG Barkin J Siami P | 2011 | BJU interna-tional2011，107，6： | 1 |
| 10 | The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study 显示文摘 | Roehrborn CG Siami P Barkin J | 2010 | Eur Urol2010，57，： | 1 |
| 11 | The effects of dutasteride, tamsulosin, and the combination on storage and voiding in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the combination of avodart and tamsulosin study 显示文摘 | Becher E Roehrborn CG Siami P | 2009 | Prostate Cancer Prostatic Dis2009，12，4： | 1 |
| 12 | The influence of baseline parameters on changes in international prostate symptom score with dutasteride,tamsulosin,and combination therapy among men with symptomatic benign prostatic hyperplasia and an enlarged prostate:2-year data from the combat study显示文摘 | Roehrborn CG Siami P Barkin J | 2009 | Eur Urol2009，55，2： | 1 |
| 13 | The effects of combination therapy with dutasteride and tamsulsin on clinical outcome in men with symptomatic benign prostatic hyperplasia :4-yers result from the CombAT study显示文摘 | Roehrborn CG Siami P Barkin J | 2010 | Eur Uro12010，57，1： | 1 |
| 14 | The influence of baseline parameters on changes in international prostate symptom score with dutasteride, tamsulosin, and combination therapy among men with symptomatic benign prostatic hyperplasia and an e~arged prostate:2-year data from the CombAT study显示文摘 | Roehrborn CG Siami P Barkin J | 2009 | Eur Urol2009，55，2： | 1 |
| 15 | The influence of baseline parameters on changes in international prostate symptom score with dutasteride, tamsulosin, and combination therapy among men with symptomatic benign prostatic hyperplasia and an enlarged prostate: 2-year data from the CombAT study 显示文摘 | Roehrborn CG Siami P Barkin J | 2009 | Eur Urol2009，55，2： | 1 |
| 16 | Efficacy and safety of dutasteride,tamsulosin and their combination in a subpopulation of the CombAT study:2 -year results in Asian men with moder- ate-to-severe BPH 显示文摘 | Chung BH Roehrbom CG Siami P | 2009 | Prostate Cancer Prostatic Dis2009，12，2： | 1 |
| 17 | Effect ofdutasteride,tamsulosin and the combination on patientreportedquality of life and treatment satisfaction in menwith moderate-to-severe benign prostatic hyperplasia :2-year data from the CombAT trial显示文摘 | Barkin J Roehrborn CG Siami P | 2009 | BJU Int2009，103，7： | 1 |
| 18 | Ffficary and safety of dutasteride, tamsulosin and their combination in a subpopulation of the CombAT study: 2-year results in Asian men with moderate to severe BPH显示文摘 | Chung BH Roehrbom CG Siami P | 2010 | Prostate Can- cer Prostatic Dis2010，12，2： | 1 |
| 19 | Effect of dutasteride, tamsu- losin and the combination on patient-reported quality of life and treatment satisfaction in men with moderate to severe benign prostat- ic hyperplasia:2 year data from the Comb AT trial显示文摘 | Barkin J Roehrborn CG Siami P | 2009 | BJU interna- tiona!2009，103，7： | 1 |
| 20 | The efects of combination thempy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4 -year results from the CombAT study 显示文摘 | Roehrbom CG Siami P Barkin J | 2010 | Eur Urol2010，57，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员